MYC and neoplasm: Momordin Ic(MI), an emerging SENP1 inhibitor, can act as an anti-cancer drug by inhibiting the de-SUMOylation of c-Myc and reducing the level of c-Myc protein, which lead to cell cycle arrest and apoptosis of tumor cells [15].